|
LOC401397 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.438000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.589600E-01 |
| Normal-vs-Stage2 |
8.187600E-01 |
| Normal-vs-Stage3 |
8.842900E-03 |
| Normal-vs-Stage4 |
1.628920E-04 |
| Stage1-vs-Stage2 |
1.894200E-01 |
| Stage1-vs-Stage3 |
4.384100E-02 |
| Stage1-vs-Stage4 |
6.386400E-04 |
| Stage2-vs-Stage3 |
8.123400E-03 |
| Stage2-vs-Stage4 |
3.207300E-04 |
| Stage3-vs-Stage4 |
1.562170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.264300E-02 |
| Normal-vs-AfricanAmerican |
2.144800E-03 |
| Normal-vs-Asian |
6.846200E-01 |
| Caucasian-vs-AfricanAmerican |
7.806200E-02 |
| Caucasian-vs-Asian |
1.326030E-01 |
| AfricanAmerican-vs-Asian |
1.571740E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.179600E-02 |
| Normal-vs-Female |
1.187980E-01 |
| Male-vs-Female |
6.335000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.569400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.890290E-02 |
| Normal-vs-Age(61-80Yrs) |
7.426400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.255000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.243010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.935400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.040600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.450200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.267800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.381200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.897840E-01 |
| Classical-VS-Follicular |
1.05729999977378E-07 |
| Classical-VS-Other |
8.376400E-02 |
| Classical-VS-Normal |
7.224800E-03 |
| Tall-VS-Follicular |
2.19280000046673E-07 |
| Tall-VS-Other |
1.087960E-02 |
| Tall-VS-Normal |
1.544460E-03 |
| Follicular-VS-Other |
7.172200E-01 |
| Follicular-VS-Normal |
3.648200E-02 |
| Other-VS-Normal |
5.338600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.603600E-01 |
| Normal-vs-N1 |
2.424400E-02 |
| N0-vs-N1 |
6.635500E-02 |
|
|
